BIOT
Closed
Biotech Acquisition Co
10.15
0.00 (0.00%)
Last Update: 10 Feb 2023 17:30:00
Yesterday: 10.15
Day's Range: 10.15 - 10.15
Send
sign up or login to leave a comment!
When Written:
10.15
Biotech Acquisition Co is a special purpose acquisition company (SPAC) that was formed in 2020 with the aim of acquiring a biotechnology company. A SPAC is a type of investment vehicle that raises funds through an initial public offering (IPO) and then uses those funds to acquire an existing company. Biotech Acquisition Co raised $300 million in its IPO and is led by CEO Kevin Tang, who is also the founder and CEO of Tang Capital Management, a biotech-focused investment firm.
Biotech Acquisition Co's prospectus states that it is focused on acquiring a company that is developing therapeutics for unmet medical needs in areas such as oncology, immunology, and rare diseases. The company has not yet announced any specific acquisition targets, but it has until December 2022 to complete a transaction or return the funds to its investors.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Biotech Acquisition Co's prospectus states that it is focused on acquiring a company that is developing therapeutics for unmet medical needs in areas such as oncology, immunology, and rare diseases. The company has not yet announced any specific acquisition targets, but it has until December 2022 to complete a transaction or return the funds to its investors.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








